Last reviewed · How we verify
Tafamidis (Reference) (tafamidis-reference)
At a glance
| Generic name | tafamidis-reference |
|---|---|
| Sponsor | Pfizer |
| Drug class | Stabilizer |
| Target | TTR protein |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
- Chronic Familial Amyloid Polyneuropathy (hATTR) in adults with a family history of the disease
Common side effects
Drug interactions
- Warfarin
- P-glycoprotein inducers (e.g., rifampin, phenytoin)
- P-glycoprotein inhibitors (e.g., verapamil, quinidine)
Key clinical trials
- A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions (PHASE1)
- A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults (PHASE1)
- A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults (PHASE1)
- A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food (PHASE1)
- A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tafamidis (Reference) CI brief — competitive landscape report
- Tafamidis (Reference) updates RSS · CI watch RSS
- Pfizer portfolio CI